Bladder cancer is a cancer that develops in the cells lining the urinary bladder. The most common type is urothelial carcinoma, although other types of bladder cancer can also occur.
Treatment depends on several factors, including the type of bladder cancer, its stage and grade, the location and number of tumors, previous treatment and the patient's overall health. Dr. Yash R. Godbole provides urological evaluation and individualized treatment planning for patients with bladder cancer in Thane.
Bladder cancer begins when abnormal cells in the urinary bladder grow uncontrollably and form a tumor. The bladder is a hollow muscular organ that stores urine before it leaves the body.
Most bladder cancers begin in the urothelial cells that line the inside of the bladder. Some tumors remain confined to the inner layers of the bladder, while others can invade deeper layers or spread to lymph nodes and other parts of the body.
Bladder cancer can develop from different types of cells. The type of cancer identified on pathological examination helps guide treatment planning.
Also called transitional cell carcinoma, this is the most common type of bladder cancer and begins in the urothelial cells lining the bladder.
This is less common and may be associated with long-term irritation or inflammation of the bladder.
A rare type of bladder cancer that develops from glandular cells of the bladder.
Other uncommon tumors can occur in the bladder and may require specialized pathological and oncological evaluation.
Symptoms can vary depending on the tumor and the stage of the disease. Some bladder cancers may initially cause few symptoms and may be detected during evaluation for urinary problems.
Hematuria, or blood in the urine, is an important symptom and may be visible or detected only during urine testing.
Some patients may experience a frequent need to pass urine or changes in their usual urinary pattern.
Burning, discomfort or pain while passing urine may occur in some patients.
Discomfort or pain in the lower abdomen or pelvic region may occur, particularly with more advanced disease.
Blood in the urine should not be ignored. Hematuria can have several causes, including urinary infection, stones and other urinary tract conditions. A urological evaluation is important to determine the underlying cause.
The exact cause of bladder cancer may not always be identifiable. Certain factors are associated with an increased risk of developing bladder cancer.
Staging describes how far the cancer has spread, while grading describes how abnormal the cancer cells appear under microscopic examination. Both are important when planning treatment.
The cancer is limited to the inner layers of the bladder and has not invaded the bladder muscle.
The cancer has grown into the muscular layer of the bladder and may require more extensive treatment.
In advanced disease, cancer may extend outside the bladder, involve lymph nodes or spread to distant organs.
Grade provides information about how abnormal the cancer cells appear and can help assess the behavior of the tumor.
Diagnosis begins with a detailed medical history and urological evaluation. Additional investigations are selected according to the patient's symptoms and clinical findings.
Examination of the tumor tissue helps determine the type, grade and depth of cancer involvement. These findings are important for selecting an appropriate treatment and follow-up plan.
Prompt medical evaluation is important when urinary symptoms are persistent, unexplained or associated with blood in the urine.
Treatment is individualized according to the type, stage and grade of bladder cancer. The number and characteristics of tumors, previous treatment and the patient's overall health are also considered.
A cystoscope is passed through the urinary passage to remove or resect visible bladder tumors without an external incision.
Selected non-muscle-invasive bladder cancers may be treated with medicines placed directly inside the bladder.
Selected muscle-invasive or advanced bladder cancers may require removal of the bladder as part of a comprehensive treatment plan.
Depending on the stage and clinical situation, chemotherapy, immunotherapy or other systemic treatments may form part of cancer care.
One commonly used surgical approach for diagnosing and treating a bladder tumor is transurethral resection of bladder tumor (TURBT). The exact procedure depends on the size, number, location and characteristics of the tumor.
Medical history, urine tests, imaging and other investigations are reviewed before the procedure.
The procedure is performed under appropriate anesthesia with monitoring by the medical team.
A specialized instrument is passed through the urinary passage to visualize the bladder and identify the tumor.
The visible bladder tumor is removed or resected through the instrument, and tissue is collected for pathological testing.
The removed tissue is examined to determine the type, grade and depth of tumor involvement.
Based on the pathology and staging information, additional treatment or surveillance may be recommended.
Preparation depends on the planned investigation or treatment. Your urologist will provide specific instructions based on your condition.
Recovery depends on the type of treatment performed and the overall condition of the patient. Recovery following a transurethral procedure is generally different from recovery after major bladder surgery.
Urine output, bleeding and urinary symptoms may be monitored after bladder procedures.
A urinary catheter may be required temporarily after selected bladder procedures.
Normal activities are resumed gradually according to the treating doctor's instructions.
Follow-up visits and further bladder examinations may be required depending on the type and stage of cancer.
Appropriate treatment can help manage bladder tumors before disease progression in selected patients.
Removal and pathological examination of a tumor can provide important information about its type and characteristics.
Treatment can be planned according to the patient's tumor characteristics, stage and overall health.
Structured follow-up can help identify recurrence or progression and guide further management when required.
The risks of bladder cancer treatment vary according to the procedure and the stage of disease. Your doctor will explain procedure-specific risks before treatment.
After treatment, contact your treating team promptly if you develop high fever, severe pain, heavy or persistent bleeding, inability to pass urine, persistent vomiting or other concerning symptoms.
Follow-up is an important part of bladder cancer care because some bladder cancers can recur after treatment. The follow-up schedule depends on the type, grade and stage of the tumor and previous treatment.
The expected outcome depends on the type of bladder cancer, tumor grade, stage, depth of invasion, response to treatment and overall health. Bladder cancer can behave differently from one patient to another.
Some patients with non-muscle-invasive bladder cancer can be managed with tumor removal and bladder-directed treatment followed by regular surveillance. More advanced disease may require additional or more extensive treatment.
Continued monitoring after treatment helps the urologist assess the bladder and identify recurrence or progression when it occurs. Follow-up should be based on the individual's cancer characteristics and treatment history.
The cost of bladder cancer treatment can vary considerably because treatment differs according to the type and stage of cancer and the procedure required.
A personalized treatment estimate can be discussed after evaluating the patient's clinical condition, investigation reports and treatment requirements.
Bladder cancer occurs when abnormal cells in the bladder grow uncontrollably and form a tumor. Urothelial carcinoma is the most common type.
Blood in the urine, known as hematuria, is an important symptom of bladder cancer. It may be visible or detected through urine testing.
No. Blood in the urine can have several causes, including urinary infection, kidney or urinary stones and other conditions. However, unexplained hematuria should be evaluated by a doctor.
Evaluation may include urine tests, imaging and cystoscopy. A tissue sample obtained during a bladder procedure may be examined to confirm the diagnosis and determine tumor characteristics.
TURBT stands for transurethral resection of bladder tumor. It involves using an instrument passed through the urinary passage to examine and remove bladder tumor tissue.
Selected bladder cancers, particularly some non-muscle- invasive tumors, may be managed with bladder-preserving treatment. The appropriate approach depends on the tumor's characteristics and stage.
Stage describes how far the cancer has spread, while grade describes how abnormal the cancer cells appear under a microscope. Both can help guide treatment planning.
Yes. Some bladder cancers can recur after treatment. Regular follow-up is therefore an important part of long-term bladder cancer care.
Cystoscopic surveillance may be recommended depending on the type, grade and stage of bladder cancer and the previous treatment.
No. Treatment is individualized according to tumor type, stage, grade, number and location of tumors, previous treatment and the patient's overall health.
You should seek urological evaluation for unexplained blood in the urine, persistent urinary symptoms, recurrent urinary problems or a previously diagnosed bladder tumor requiring follow-up.
Dr. Yash R. Godbole is a Consultant Urologist & Andrologist providing evaluation and individualized urological care for patients with bladder and urinary tract conditions.
Consult Dr. Yash R. Godbole for evaluation of bladder cancer, discussion of treatment options and individualized urological care.
Medical Disclaimer: The information provided on this page is for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis or treatment. Bladder cancer treatment depends on the type, grade, stage and individual clinical findings. Please consult a qualified urologist for personalized medical advice.